Maxim Group Downgrades Synthetic Biologics (SYN) to Hold Amid Delays
Tweet Send to a Friend
Maxim Group downgraded Synthetic Biologics (NYSE: SYN) from Buy to Hold with a price target of $3.00 (unchanged). The change ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE